AiCure

AiCure wins 2016 Scrip Award

Thursday, December 1, 2016

AiCure, which uses artificial intelligence (AI) on mobile devices to visually confirm medication ingestion, are the winners of the 2016 Scrip Award in the category of Best Technological Development in Clinical Trials. Judges from industry, academia and finance rewarded the artificial intelligence platform for its unique contribution in driving efficiencies and quality data in clinical research.

[Read More]

High risk of ignoring individual patterns of medication adherence

Tuesday, March 15, 2016

Hundreds of millions of dollars are spent ensuring operational quality in clinical trials includ­ing site compliance, accuracy of data entry and enrollment targets. Meanwhile, one of the most vul­nerable aspects of the process—whether or not study participants are taking the investigation com­pound—receives surprisingly scant attention.

[Read More]

AiCure tests artificial intelligence in opioid trial

Monday, November 24, 2014

AiCure, a New York-based artificial intelligence company providing advanced facial recognition and motion-sensing technology to monitor medication ingestion, has announced the start of a major clinical trial to monitor and intervene with patients receiving medication as maintenance therapy for opioid addiction.

[Read More]